Linical Co., Ltd. (2183.T)
JPY 290.0
(-0.68%)
JPY 290.0
(-0.68%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 12.3 Billion JPY | -1.67% |
| 2022 | 12.51 Billion JPY | 8.32% |
| 2021 | 11.55 Billion JPY | 12.41% |
| 2020 | 10.27 Billion JPY | -6.0% |
| 2019 | 10.93 Billion JPY | -3.34% |
| 2018 | 11.31 Billion JPY | 24.14% |
| 2017 | 9.11 Billion JPY | 9.06% |
| 2016 | 8.35 Billion JPY | 8.99% |
| 2015 | 7.66 Billion JPY | 57.36% |
| 2014 | 4.87 Billion JPY | 30.9% |
| 2013 | 3.72 Billion JPY | 3.41% |
| 2012 | 3.59 Billion JPY | 15.72% |
| 2011 | 3.11 Billion JPY | 23.81% |
| 2010 | 2.51 Billion JPY | 4.48% |
| 2009 | 2.4 Billion JPY | 18.09% |
| 2008 | 2.03 Billion JPY | 59.93% |
| 2007 | 1.27 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.92 Billion JPY | -4.35% |
| 2023 Q1 | 3.08 Billion JPY | -5.76% |
| 2023 Q3 | 3.18 Billion JPY | 6.77% |
| 2023 FY | 12.3 Billion JPY | -1.67% |
| 2023 Q4 | 3.05 Billion JPY | -3.93% |
| 2023 Q2 | 2.98 Billion JPY | -3.24% |
| 2022 FY | 12.51 Billion JPY | 8.32% |
| 2022 Q4 | 3.27 Billion JPY | -1.67% |
| 2022 Q3 | 3.32 Billion JPY | 8.98% |
| 2022 Q2 | 3.05 Billion JPY | 6.37% |
| 2022 Q1 | 2.86 Billion JPY | -2.46% |
| 2021 Q1 | 2.78 Billion JPY | 1.37% |
| 2021 Q2 | 2.73 Billion JPY | -1.69% |
| 2021 Q3 | 3.09 Billion JPY | 12.91% |
| 2021 Q4 | 2.94 Billion JPY | -4.85% |
| 2021 FY | 11.55 Billion JPY | 12.41% |
| 2020 Q2 | 2.55 Billion JPY | 5.52% |
| 2020 Q3 | 2.55 Billion JPY | -0.29% |
| 2020 FY | 10.27 Billion JPY | -6.0% |
| 2020 Q4 | 2.74 Billion JPY | 7.71% |
| 2020 Q1 | 2.42 Billion JPY | -11.21% |
| 2019 Q2 | 2.7 Billion JPY | 1.1% |
| 2019 Q1 | 2.68 Billion JPY | -2.13% |
| 2019 Q3 | 2.81 Billion JPY | 3.9% |
| 2019 Q4 | 2.73 Billion JPY | -3.02% |
| 2019 FY | 10.93 Billion JPY | -3.34% |
| 2018 FY | 11.31 Billion JPY | 24.14% |
| 2018 Q4 | 2.73 Billion JPY | -7.56% |
| 2018 Q3 | 2.96 Billion JPY | 3.83% |
| 2018 Q2 | 2.85 Billion JPY | 3.42% |
| 2018 Q1 | 2.75 Billion JPY | 14.93% |
| 2017 Q4 | 2.4 Billion JPY | 0.33% |
| 2017 FY | 9.11 Billion JPY | 9.06% |
| 2017 Q2 | 2.18 Billion JPY | 2.18% |
| 2017 Q3 | 2.39 Billion JPY | 9.61% |
| 2017 Q1 | 2.13 Billion JPY | -1.0% |
| 2016 FY | 8.35 Billion JPY | 8.99% |
| 2016 Q3 | 2.16 Billion JPY | 4.34% |
| 2016 Q2 | 2.07 Billion JPY | 6.55% |
| 2016 Q4 | 2.15 Billion JPY | -0.49% |
| 2016 Q1 | 1.95 Billion JPY | 0.85% |
| 2015 FY | 7.66 Billion JPY | 57.36% |
| 2015 Q4 | 1.93 Billion JPY | -0.94% |
| 2015 Q3 | 1.95 Billion JPY | -4.94% |
| 2015 Q2 | 2.05 Billion JPY | 19.02% |
| 2015 Q1 | 1.72 Billion JPY | 2.26% |
| 2014 FY | 4.87 Billion JPY | 30.9% |
| 2014 Q4 | 1.68 Billion JPY | 43.41% |
| 2014 Q3 | 1.17 Billion JPY | 22.69% |
| 2014 Q2 | 959.14 Million JPY | -8.53% |
| 2014 Q1 | 1.04 Billion JPY | 0.08% |
| 2013 Q1 | 860.65 Million JPY | -15.45% |
| 2013 FY | 3.72 Billion JPY | 3.41% |
| 2013 Q3 | 967.37 Million JPY | 14.33% |
| 2013 Q4 | 1.04 Billion JPY | 8.3% |
| 2013 Q2 | 846.12 Million JPY | -1.69% |
| 2012 Q3 | 858.03 Million JPY | 5.25% |
| 2012 Q1 | 908.09 Million JPY | -0.49% |
| 2012 Q2 | 815.23 Million JPY | -10.23% |
| 2012 Q4 | 1.01 Billion JPY | 18.63% |
| 2012 FY | 3.59 Billion JPY | 15.72% |
| 2011 FY | 3.11 Billion JPY | 23.81% |
| 2011 Q1 | 650.49 Million JPY | 1.83% |
| 2011 Q2 | 730.69 Million JPY | 12.33% |
| 2011 Q3 | 816.51 Million JPY | 11.74% |
| 2011 Q4 | 912.53 Million JPY | 11.76% |
| 2010 FY | 2.51 Billion JPY | 4.48% |
| 2010 Q2 | 614.71 Million JPY | -4.39% |
| 2010 Q1 | 642.97 Million JPY | -2.36% |
| 2010 Q3 | 615.5 Million JPY | 0.13% |
| 2010 Q4 | 638.82 Million JPY | 3.79% |
| 2009 Q1 | 689.62 Million JPY | -1.85% |
| 2009 FY | 2.4 Billion JPY | 18.09% |
| 2009 Q4 | 658.49 Million JPY | 29.92% |
| 2009 Q3 | 506.83 Million JPY | -7.75% |
| 2009 Q2 | 549.38 Million JPY | -20.34% |
| 2008 Q4 | 702.58 Million JPY | 39.99% |
| 2008 Q2 | 428.62 Million JPY | 0.0% |
| 2008 FY | 2.03 Billion JPY | 59.93% |
| 2008 Q3 | 501.86 Million JPY | 17.09% |
| 2007 FY | 1.27 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | -158.021% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -10799.058% |
| GNI Group Ltd. | 26.01 Billion JPY | 52.681% |
| Trans Genic Inc. | 13.08 Billion JPY | 5.928% |
| MEDINET Co., Ltd. | 661.54 Million JPY | -1760.479% |
| Soiken Holdings Inc. | 5.15 Billion JPY | -138.596% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | -688.77% |
| AnGes, Inc. | 152.98 Million JPY | -7945.148% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | -1917.293% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 3.589% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | -1407.023% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -8982.763% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | -656.993% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -2773.227% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | -547.373% |
| Chiome Bioscience Inc. | 682.46 Million JPY | -1703.446% |
| Kidswell Bio Corporation | 2.43 Billion JPY | -406.239% |
| PeptiDream Inc. | 28.71 Billion JPY | 57.134% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -19424.525% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -10071.793% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -17094163.889% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -30756.846% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | -172.869% |
| FunPep Company Limited | 530 Thousand JPY | -2322139.623% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -17673.097% |
| Stella Pharma Corporation | 269.49 Million JPY | -4467.08% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -3784.839% |
| Cuorips Inc. | 23.1 Million JPY | -53176.21% |
| K Pharma,Inc. | 1 Billion JPY | -1130.787% |
| Takara Bio Inc. | 43.5 Billion JPY | 71.709% |
| ReproCELL Incorporated | 2.42 Billion JPY | -407.161% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | -617.526% |
| StemCell Institute Inc. | 2.48 Billion JPY | -396.046% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | -389.536% |
| CellSeed Inc. | 190.13 Million JPY | -6373.261% |